Clinical Trial Update: Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the use of bortezomib in multiple myeloma patients who have undergone autologous peripheral blood stem cell transplanta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• Bortezomib (Velcade) (Bortezomib)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 1 | Status: COMPLETED